Skip to Content

Geisinger Commonwealth School of Medicine Faculty

  • Sign in to your Merit page
« Back to Recent News

Geisinger Commonwealth School of Medicine professor published in prestigious journal

Paper identifies a mechanism that may lead to a potential drug target for endocrine-related diseases

Scranton, PA (11/21/2017) — Raj Kumar, Ph.D., a professor of biochemistry and the director of research at Geisinger Commonwealth School of Medicine (Geisinger Commonwealth), is the lead author of a research article published on Nov. 13 in the online journal, Scientific Reports. Scientific Reports is a sister publication of Nature.

The article, Site-specific phosphorylation regulates the structure and function of an intrinsically disordered domain of the glucocorticoid receptor, was co-authored by Shagufta H. Khan, laboratory manager of Geisinger Commonwealth's department of Basic Sciences and William A. McLaughlin, Ph.D., associate professor of computational biology.

The paper identifies a mechanism of activation of the glucocorticoid receptor (GR) that may lead to a potential drug target for endocrine-related diseases including certain kinds of breast and prostate cancers that fail to respond to traditional hormone-based treatments. Phosphorylation is a natural and necessary post-translational modification that proteins undergo to maintain their specific structure and functions under normal physiological conditions. In specific types of cancer cells - triple negative breast cancer (TNBC) and castration-resistant prostate cancer - higher expression and activity of GR have been associated with the growth and proliferation of these cells. Dr. Kumar's research suggests that inhibiting phosphorylation-induced GR activation process could stop or slow the growth of these cancers.

"Ours is a novel finding, which provides a potential biological target for TNBC and possibly other cancers" Dr. Kumar said. "The next step in our research is to test whether certain small molecules can inhibit site-specific GR phosphorylation. If they do, there may be a new drug target for TNBC and possibly castration-resistant prostate cancer, both of which presently have little treatment options available.
To read the paper, visit www.nature.com/articles/s41598-017-15549-5.

Media Attachments

Raj Kumar, Ph.D., professor of biochemistry and the director of research at Geisinger Commonwealth School of Medicine

William A. McLaughlin, Ph.D., associate professor of computational biology at Geisinger Commonwealth School of Medicine


WM
William
McLaughlin
  • Assoc Professor - Comp Biology
  • Computational Biology
  • Clarks Summit
RK
Raj
Kumar
  • Professor - Biochemistry
  • Biochemistry
  • Clarks Summit

Geisinger Commonwealth School of Medicine Faculty

EZygmunt@som.geisinger.edu

Share this Story

  • Print
  • Email

Recent News

  • Geisinger College leader completes prestigious fellowship program
  • Geisinger College of Health Sciences vice provost rejoins Harvard Macy Institute's Program for Educators in Health Professions
  • Geisinger Commonwealth associate dean elected president of the Academy for Professionalism in Health Care
  • Geisinger Commonwealth School of Medicine faculty publish research
  • Michelle Schmude, EdD, invited to speak at Association of American Medical Colleges' (AAMC) Health Professions Financial Aid Administrators Conference
  • Geisinger Commonwealth School of Medicine associate dean, medical studentaddress AAMC conference
  • Geisinger Commonwealth School of Medicine's associate dean for admissions appointed to boards
  • Dr. Michelle Schmude invited to participate in Tour 4 Diversity panel
  • Geisinger Commonwealth School of Medicine faculty member to conduct virtual training for University of Nebraska Medical Center
  • Geisinger Commonwealth School of Medicine faculty, students invited to present on e-Portfolio project research at two national conferences
… View all recent news
Copyright © 2025 Merit Pages, Inc. • All Rights Reserved. • Terms of Service • Privacy Policy • Opt Out